Literature DB >> 14888894

Studies on the chemotherapy of vaccinia virus. II. The activity of some thiosemicarbazones.

D HAMRE, K A BROWNLEE, R DONOVICK.   

Abstract

Entities:  

Keywords:  THIOSEMICARBAZONES/effects; VACCINIA

Mesh:

Substances:

Year:  1951        PMID: 14888894

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  16 in total

1.  PNEUMOCYSTIS CARINII PENUMONIA AND PROGRESSIVE VACCINIA IN SIBLINGS.

Authors:  E C ALLIBONE; W GOLDIE; B P MARMION
Journal:  Arch Dis Child       Date:  1964-02       Impact factor: 3.791

2.  [Effect of thiosemicarbazone in experimental smallpox infections in mice].

Authors:  M BOCK
Journal:  Z Hyg Infektionskr       Date:  1957

3.  [Virus diseases in otorhinolaryngology region].

Authors:  R HAAS
Journal:  Arch Ohren Nasen Kehlkopfheilkd       Date:  1955-05-02

4.  A screening test of the effect of organic compounds on production of tobacco mosaic virus.

Authors:  D E SCHLEGEL; T E RAWLINS
Journal:  J Bacteriol       Date:  1954-01       Impact factor: 3.490

5.  The specific effectors of viral development.

Authors:  A Lwoff
Journal:  Biochem J       Date:  1965-08       Impact factor: 3.857

Review 6.  Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

Review 7.  In search of a selective antiviral chemotherapy.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

8.  Historical perspectives in the development of antiviral agents against poxviruses.

Authors:  Erik De Clercq
Journal:  Viruses       Date:  2010-06-14       Impact factor: 5.818

9.  Antiviral chemotherapy.

Authors:  I TAMM
Journal:  Yale J Biol Med       Date:  1956-09

Review 10.  From actually toxic to highly specific--novel drugs against poxviruses.

Authors:  Katja Sliva; Barbara Schnierle
Journal:  Virol J       Date:  2007-01-15       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.